Search in:

Advanced search

Postgraduate Medicine Volume 134, 2022 - Issue 1

Submit an article Journal homepage

2,031

Views

CrossRef citations to date

Altmetric

Clinical features - Original research

Ferritin as prognostic marker in COVID-19: the FerVid study

Ombretta Paraa Internal Medicine Unit 1, University Hospital Careggi, Florence, ItalyView further author information

Lorenzo Carusoa Internal Medicine Unit 1, University Hospital Careggi, Florence, ItalyCorrespondence[email protected]
View further author information

Giulia Pestellia Internal Medicine Unit 1, University Hospital Careggi, Florence, ItalyView further author information

Flavio Tangianub Department of Medicine and Surgery, University of Insubria, Varese, ItalyView further author information

Davide Carrarac U.O.C. General Medicine, Versilia Hospital, Viareggio, ItalyView further author information

Lucia Maddalunia Internal Medicine Unit 1, University Hospital Careggi, Florence, ItalyView further author information

Antonio Tamburellod Department of Internal Medicine, Hospital of Legnano, Legnano, ItalyView further author information

Laura Castelnovod Department of Internal Medicine, Hospital of Legnano, Legnano, ItalyView further author information

Giacomo Fedia Internal Medicine Unit 1, University Hospital Careggi, Florence, ItalyView further author information

Stefano Guidia Internal Medicine Unit 1, University Hospital Careggi, Florence, ItalyView further author information

Caterina Pestellia Internal Medicine Unit 1, University Hospital Careggi, Florence, ItalyView further author information

Benedetta Pennellab Department of Medicine and Surgery, University of Insubria, Varese, ItalyView further author information

Tiziana Ciarambinoe Hospital of Marcianise, ASL Caserta, Caserta, ItalyView further author information

Carlo Nozzolia Internal Medicine Unit 1, University Hospital Careggi, Florence, ItalyView further author information

Francesco Dentalib Department of Medicine and Surgery, University of Insubria, Varese, Italy

https://orcid.org/0000-0003-4195-7725 View further author information

show all

Pages 58-63 | Received 04 May 2021, Accepted 09 Sep 2021, Published online: 17 Oct 2021

Cite this article
https://doi.org/10.1080/00325481.2021.1990091
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

References

Rosário C, Zandman-Goddard G, Meyron-Holtz EG, et al. The hyperferritinemic syndrome: macrophage activation syndrome, still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med [Internet]. 2013 Aug 22 [cited 2020 July 28];11(1):185. Available from: /pmc/articles/PMC3751883/?report=abstract
PubMed Web of Science ®Google Scholar
Gómez-Pastora J, Weigand M, Kim J, et al. Hyperferritinemia in critically ill COVID-19 patients – is ferritin the product of inflammation or a pathogenic mediator? [Internet]. Clin Chim Acta. 2020 [cited 2020 July 28];509:249–251. Elsevier B.V. Available from:. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306200/
PubMed Web of Science ®Google Scholar
McGonagle D, Sharif K, O’Regan A, et al. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease [Internet]. Autoimmun Rev. 2020 [cited 2020 July 28];19:102537. Elsevier B.V. Available from:. https://pubmed.ncbi.nlm.nih.gov/32251717/
Web of Science ®Google Scholar
Von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. UroToday Int J [Internet]. 2009 [cited 2020 Sep 16];2(2):806. Available from: /pmc/articles/PMC2034723/?report=abstract
Google Scholar
Long H, Nie L, Xiang X, et al. D-dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis. Biomed Res Int [Internet]. 2020 [cited 2020 July 29];2020:1–10. Available from: /pmc/articles/PMC7301188/?report=abstract
Web of Science ®Google Scholar
Soraya GV, Ulhaq ZS. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: an updated meta-analysis. Med Clin (Barc) [Internet] 2020 [cited 2020 July 29];155:143–151. Available from: /pmc/articles/PMC7274591/?report=abstract
Web of Science ®Google Scholar
Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol [Internet]. 2020 July 10 [cited 2020 July 29];7:e671–e678. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32659214
PubMed Web of Science ®Google Scholar
Ruan Q, Yang K, Wang W, et al. Correction to: clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China (Intensive Care Medicine, (2020), 46, 5, (846-848), https://doi.org/10.1007/s00134-020-05991-x) [Internet]. Intensive Care Med. 2020 [cited 2020 Sept 4];46:1294–1297. Springer.
PubMed Web of Science ®Google Scholar
Huang I, Pranata R, Lim MA, et al. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis [Internet]. 2020 Jan 1 [cited 2020 Sept 4];14:175346662093717. Available from: https://covid19.elsevierpure.com/it/publications/c-reactive-protein-procalcitonin-d-dimer-and-ferritin-in-severe-c
Web of Science ®Google Scholar
Recalcati S, Invernizzi P, Arosio P, et al. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun [Internet]. 2008 Feb [cited 2020 July 28];30(1–2):84–89. Available from: https://ucdavis.pure.elsevier.com/en/publications/new-functions-for-an-iron-storage-protein-the-role-of-ferritin-in
PubMed Web of Science ®Google Scholar
Shoenfeld Y. Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning [Internet]. Autoimmun Rev. 2020 [cited 2020 July 28];19:102538. Elsevier B.V. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131471/
PubMed Web of Science ®Google Scholar
Zhang W, Zhao Y, Zhang F, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China [Internet]. Clin Immunol. 2020 [cited 2020 July 28];214:108393. Academic Press Inc. Available from: https://pubmed.ncbi.nlm.nih.gov/32222466/
Web of Science ®Google Scholar
Ruscitti P, Berardicurti O, Iagnocco A, et al. Cytokine storm syndrome in severe COVID-19 [Internet]. Autoimmun Rev. 2020 [cited 2020 July 28];19:102562. Elsevier B.V. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252135/
PubMed Web of Science ®Google Scholar
Colafrancesco S, Priori R, Alessandri C, et al. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia. Immunol Res [Internet]. 2014 Dec 9 [cited 2020 July 29];60(2–3):177–183. Available from: https://pubmed.ncbi.nlm.nih.gov/25388964/
PubMed Web of Science ®Google Scholar
Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect [Internet]. 2020 June 1 [cited 2020 July 28];80(6):656–665. Available from: /pmc/articles/PMC7151416/?report=abstract
PubMed Web of Science ®Google Scholar
Madoiwa S. Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC [Internet]. J Intensive Care. 2015 [cited 2020 July 28];3:8. BioMed Central Ltd. Available from: /pmc/articles/PMC4940964/?report=abstract
PubMed Web of Science ®Google Scholar
RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19 — preliminary report. N Engl J Med [Internet]. 2020 July 17 [cited 2020 July 29];NEJMoa2021436. Available from: http://www.nejm.org/doi/https://doi.org/10.1056/NEJMoa2021436
PubMed Web of Science ®Google Scholar
Alzghari SK, Acuña VS. Supportive treatment with tocilizumab for COVID-19: a systematic review. J Clin Virol [Internet]. 2020 June 1 [cited 2020 Sep 16];127:104380. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194791/
PubMed Web of Science ®Google Scholar
Khiali S, Khani E, Entezari-Maleki T, et al. Review of tocilizumab in COVID-19 acute respiratory distress syndrome [Internet]. J Clin Pharmacol. 2020 [cited 2020 Sept 16];60:1131–1146. Blackwell Publishing Inc. Available from: https://pubmed.ncbi.nlm.nih.gov/32557541/
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Ferritin as prognostic marker in COVID-19: the FerVid study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Ferritin as prognostic marker in COVID-19: the FerVid study

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date